Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4689 - 4696 of 11616 results
TCPA Class Action Update: Commercial Purpose? Not Enough.
June 17, 2019| Article| Viewpoint
Mintz Associate Don Davis Calls for Congress to Pass the Equality Act
June 14, 2019| News
AB-375 Privacy: Personal Information: Businesses
June 13, 2019| Article| Viewpoint
Heritage Pharmaceuticals Admits to Generic Drug Price Fixing Scheme
June 13, 2019| Blog| Viewpoint
Canon and Toshiba Pay $5 Million for HSR Avoidance Scheme
June 13, 2019| Alert| Viewpoint
The Bubbler - June 2019
June 13, 2019| Blog| Viewpoint
What’s New In Westchester County
June 13, 2019| Blog| Viewpoint
Application to Compel Arbitration Under New York CPLR 7503: What Does It Mean to Be “Aggrieved”?
June 13, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.